Synthesis and Anti-Ovarian Cancer Effects of Benzimidazole-2-Substituted Pyridine and Phenyl Propenone Derivatives
- 14 November 2022
- journal article
- research article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 14 (24) , 1835-1846
Abstract
Background: Given the benzimidazole derivatives have anti-ovarian cancer effects, the authors aimed to determine whether benzimidazole-2-substituted pyridine and phenyl propenone derivatives exert ... Tweetable abstract The benzimidazole-2-substituted pyridine propenone derivative A-6 shows potent activity against ovarian cancer in vitro and in vivo and may be a potential antitumor agent against... Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of China (82073711)
- CAMS Innovation Fund for Medical Sciences (2021-I2M-1-030)
This publication has 34 references indexed in Scilit:
- Novel treatment options in platinum-sensitive recurrent ovarian cancer: A reviewGynecologic Oncology, 2019
- Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trialThe Lancet Oncology, 2018
- Ovarian cancer statistics, 2018CA: A Cancer Journal for Clinicians, 2018
- Advances in ovarian cancer therapyCancer Chemotherapy and Pharmacology, 2017
- Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New EraAnti-Cancer Agents in Medicinal Chemistry, 2016
- Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancerGynecologic Oncology, 2015
- Antiproliferative activity of new benzimidazole derivatives.Acta Biochimica Polonica, 2013
- Rethinking ovarian cancer: recommendations for improving outcomesNature Reviews Cancer, 2011
- First-line treatment of advanced ovarian cancer: current research and perspectivesExpert Review of Anticancer Therapy, 2010
- Ovarian cancerThe Lancet, 2009